Estimation and modeling of the restricted mean time lost in the presence of competing risks
Survival data with competing or semi‐competing risks are common in observational studies. As an alternative to cause‐specific and subdistribution hazard ratios, the between‐group difference in cause‐specific restricted mean times lost (RMTL) gives the mean difference in life expectancy lost to a spe...
Uložené v:
| Vydané v: | Statistics in medicine Ročník 40; číslo 9; s. 2177 - 2196 |
|---|---|
| Hlavní autori: | , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
Wiley Subscription Services, Inc
01.04.2021
|
| Predmet: | |
| ISSN: | 0277-6715, 1097-0258, 1097-0258 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Shrnutí: | Survival data with competing or semi‐competing risks are common in observational studies. As an alternative to cause‐specific and subdistribution hazard ratios, the between‐group difference in cause‐specific restricted mean times lost (RMTL) gives the mean difference in life expectancy lost to a specific cause of death or in disease‐free time lost, in the case of a nonfatal outcome, over a prespecified period. To adjust for covariates, we introduce an inverse probability weighted estimator and its variance for the marginal difference in RMTL. We also introduce an inverse probability of censoring weighted regression model for the RMTL. In simulation studies, we examined the finite sample performance of the proposed methods under proportional and nonproportional subdistribution hazards scenarios. We illustrated both methods with competing risks data from the Framingham Heart Study. We estimated sex differences in atrial fibrillation (AF)‐free times lost over 40 years. We also estimated sex differences in mean lifetime lost to cardiovascular disease (CVD) and non‐CVD death over 10 years among individuals with AF. |
|---|---|
| Bibliografia: | Funding information American Heart Association, 18SFRN34150007; National Heart, Lung, and Blood Institute, 75N92019D00031; HHSN268201500001I; HL145904‐01; N01‐HC25195 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ISSN: | 0277-6715 1097-0258 1097-0258 |
| DOI: | 10.1002/sim.8896 |